Investor Ideas Adds Recent #Nasdaq
IPO Stocks- Biotech, China-Asia and Energy Sectors – ($KLDO), ( $INMB), ( $SXTC),
( $MDJH)
( $MTC), ( $NFE)
Point Roberts, WA, Delta BC – March 22, 2019 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource announces this week’s additions to its global stock
directories in biotech, China-Asia and energy.
Investorideas.com is a go-to destination for retail
investors and tracks companies in high-profile trading sectors and makes
ongoing additions to its stock directories for its followers and members.
All new additions this week are recent Nasdaq IPO’s
and include biotech, energy, and China-based companies.
New biotech stocks are clinical stage biotechnology
companies involved in treatments using microbiomes and the innate immune
system, respectively.
The latest China stocks include a cross-over into
the life sciences sector of our biotech stocks directory, a fintech company and
a real estate services company.
The newest energy company is involved in the
natural gas infrastructure sector.
New Biotech Companies
Kaleido
Biosciences, Inc. (NasdaqGS:KLDO) is a clinical-stage healthcare company with a differentiated,
chemistry-driven approach to leveraging the potential of the microbiome organ
to treat disease and improve human health. The Company has built a
human-centric proprietary product platform to enable the rapid and
cost-efficient discovery and development of novel Microbiome Metabolic
Therapies (MMT™). MMTs are designed to modulate the metabolic output and
profile of the microbiome by driving the function and distribution of the
organ’s existing microbes. Kaleido is advancing a broad pipeline of MMT
candidates with the potential to address a variety of diseases and conditions
with significant unmet patient needs.
INmune BIO, INC. (NasdaqCM:INMB) is a publicly traded,
clinical-stage biotechnology company developing therapies targeting the innate
immune system to fight disease. INmune Bio is developing three product
platforms: two products that reengineer the patient’s innate immune system’s
response to cancer and one product to treat neuroinflammation that is currently
focused on Alzheimer’s disease. INKmune is a natural killer (NK) cell
therapeutic that primes the patient’s NK cells to attack minimal residual
disease, the remaining cancer cells that are difficult to detect, which often
cause relapse. INB03 inhibits myeloid derived suppressor cells (MDSC), which
often cause resistance to immunotherapy, such as anti-PD-1 checkpoint
inhibitors. XPro1595 targets neuroinflammation, which causes microglial
activation and neuronal cell death. INmune Bio’s product platforms utilize a
precision medicine approach for the treatment of a wide variety of hematologic
malignancies, solid tumors and chronic inflammation
New China/Asia Companies
CHINA
SXT PHARMACEUTICALS, INC. (NasdaqCM:SXTC) is an innovative
pharmaceutical company based in China focusing on the research, development,
manufacture, marketing and sales of traditional Chinese medicine tablets (the
“TCMP”).
MMTEC,
INC. (NasdaqCM::MTC) is a technology company in
providing access to the US markets on an omnibus and DVP basis. The core
business of MMTEC, INC. is to provide comprehensive, Internet-based technology
services and solutions to the China local hedge funds, mutual funds, registered
investment advisors, proprietary trading groups, and brokerage firms engaging
in securities market transactions and settlements globally. We help these
financial institutions to accelerate their integration into the overseas market
by offering complete suite trading solutions, including services such as fund
establishment, issuance, custody, transaction and settlement.
MDJM
LTD (NasdaqCM:MDJH) is an emerging, integrated
real estate services company in China. The Company offers primary real estate
agency services to real estate developers including integrated marketing planning,
advertising planning and strategy. The Company also provides real estate
consulting services and independent training services on an as needed basis.
Currently, the Company’s primary market is the Tianjin Autonomous Municipality
and since 2014 the Company has expanded its market presence to other cities
including Chengdu, Suzhou, and Yangzhou. Through two major development
businesses, Xishe and Xishe Xianglin, coupled with existing core business, MDJM
promotes the integration of urban and rural lifestyle services.
New Energy Companies:
NEW FORTRESS ENERGY LLC (NasdaqGS: NFE) is a global energy
infrastructure company founded to help accelerate the world’s transition to
clean energy. The company funds, builds and operates natural gas infrastructure
and logistics to rapidly deliver fully integrated, turnkey energy solutions
that enable economic growth, enhance environmental stewardship and transform
local industries and communities. New Fortress Energy is majority-owned by a
fund managed by an affiliate of Fortress Investment Group
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news and press releases plus
we create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play
sports and stock news column, Investor Ideas
#Potcasts
#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI
Eye Podcast
and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer and disclosure info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media
services at Investorideas.com
To sponsor a daily podcast for the month or to be an expert guest please
contact us!
Contact
Investorideas.com
800-665-0411